As the 2026 Winter Olympic Games come to a close, the competitions leave behind valuable lessons for both educators and students alike. This year, the premier international multisport event was hosted ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

The FDA has approved the first-ever GLP-1 pill from Wegovy maker Novo Nordisk. Novo Nordisk said the starting dose of 1.5 milligrams will be available in early January in pharmacies and via select ...

Key attitudes and strategic frameworks for intelligent and successful investors Marguerita is a Certified Financial Planner (CFP), Chartered Retirement Planning Counselor (CRPC), Retirement Income ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Starting out in investing can feel daunting. It’s easy to feel overwhelmed by the jargon, the ...

Netflix announced a 10-for-1 stock split. The fundamentals of the company stay the same, but the pricey shares will be more accessible to retail investors. The stock is currently one of 10 names in ...

WASHINGTON, DC - SEPTEMBER 19: A poster of the “Trump Gold Card” is seen as President Donald Trump delivers remarks in the Oval Office at the White House on September 19, 2025 in Washington, DC. The ...

Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, ...

The Powerball jackpot rose to $1.20 billion for the Monday, Sept. 1, drawing after no one won the top prize on Saturday, Aug. 30. If someone matches all five numbers and the Powerball, they can choose ...